FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213234788> ?p ?o ?g. }

• W4213234788 endingPage "422" @default.
• W4213234788 startingPage "411" @default.
• W4213234788 abstract "This study evaluated the incidence, management, and outcome of patients who experienced MitraClip (Abbott Vascular) failure secondary to loss of leaflet insertion (LLI), single leaflet detachment (SLD), or embolization.Transcatheter edge-to-edge repair with MitraClip is an established therapy for the treatment of mitral regurgitation (MR), but no data exist regarding the prevalence and outcome according to the mode of clip failure.Between January 2009 and December 2020, we retrospectively screened 4,294 procedures of MitraClip performed in 19 centers. LLI was defined as damage to the leaflet where the MitraClip was attached, SLD as demonstration of complete separation between the device and a single leaflet tissue, and clip embolization as loss of contact between MitraClip and both leaflets.A total of 147 cases of MitraClip failure were detected (overall incidence = 3.5%), and these were secondary to LLI or SLD in 47 (31.9%) and 99 (67.3%) cases, respectively, whereas in 1 (0.8%) case clip embolization was observed. MitraClip failure occurred in 67 (45.5%) patients with functional MR, in 64 (43.5%) patients with degenerative MR, and 16 (10.8%) with mixed etiology. Although the majority of MitraClip failures were detected before discharge (47 intraprocedural and 42 in the hospital), up to 39.5% of cases were diagnosed at follow-up. In total, 80 (54.4%) subjects underwent a redo procedure, either percutaneously with MitraClip (n = 51, 34.7%) or surgically (n = 36, 24.5%) including 4 cases of surgical conversion of the index procedure and 7 cases of bailout surgery after unsuccessful redo MitraClip. After a median follow-up of 163 days (IQR: 22-720 days), 50 (43.9%) subjects presented moderate to severe MR, and 43 (29.3%) patients died. An up-front redo MitraClip strategy was associated with a trend toward a reduced rate of death at follow-up vs surgical or conservative management (P = 0.067), whereas postprocedural acute kidney injury, age, and moderate to severe tricuspid regurgitation were independent predictors of death.MitraClip failure secondary to LLI and SLD is not a rare phenomenon and may occur during and also beyond hospitalization. Redo MitraClip strategy demonstrates a trend toward a reduced risk of death compared with bailout surgery and conservative management. A third of those patients remained with more than moderate MR and had substantial mortality at the intermediate-term follow-up." @default.
• W4213234788 created "2022-02-24" @default.
• W4213234788 creator A5001295240 @default.
• W4213234788 creator A5003293616 @default.
• W4213234788 creator A5004321997 @default.
• W4213234788 creator A5006233522 @default.
• W4213234788 creator A5011918560 @default.
• W4213234788 creator A5013041243 @default.
• W4213234788 creator A5015795674 @default.
• W4213234788 creator A5016167046 @default.
• W4213234788 creator A5022050683 @default.
• W4213234788 creator A5023950438 @default.
• W4213234788 creator A5024321268 @default.
• W4213234788 creator A5026594391 @default.
• W4213234788 creator A5029966654 @default.
• W4213234788 creator A5030343009 @default.
• W4213234788 creator A5036972757 @default.
• W4213234788 creator A5037313822 @default.
• W4213234788 creator A5038392664 @default.
• W4213234788 creator A5039789130 @default.
• W4213234788 creator A5042455711 @default.
• W4213234788 creator A5042895855 @default.
• W4213234788 creator A5045386444 @default.
• W4213234788 creator A5045707517 @default.
• W4213234788 creator A5046485954 @default.
• W4213234788 creator A5049607555 @default.
• W4213234788 creator A5050556018 @default.
• W4213234788 creator A5050815815 @default.
• W4213234788 creator A5054565426 @default.
• W4213234788 creator A5056892721 @default.
• W4213234788 creator A5057253215 @default.
• W4213234788 creator A5063911245 @default.
• W4213234788 creator A5064993872 @default.
• W4213234788 creator A5068678356 @default.
• W4213234788 creator A5069050073 @default.
• W4213234788 creator A5069065114 @default.
• W4213234788 creator A5073592971 @default.
• W4213234788 creator A5073900885 @default.
• W4213234788 creator A5076109161 @default.
• W4213234788 creator A5079119550 @default.
• W4213234788 creator A5081829248 @default.
• W4213234788 creator A5084711633 @default.
• W4213234788 creator A5085635316 @default.
• W4213234788 creator A5089649399 @default.
• W4213234788 date "2022-02-01" @default.
• W4213234788 modified "2023-10-17" @default.
• W4213234788 title "Management and Outcome of Failed Percutaneous Edge-to-Edge Mitral Valve Plasty" @default.
• W4213234788 cites W1636949889 @default.
• W4213234788 cites W1702900437 @default.
• W4213234788 cites W1739325045 @default.
• W4213234788 cites W2035448348 @default.
• W4213234788 cites W2118156772 @default.
• W4213234788 cites W2177458713 @default.
• W4213234788 cites W2179188561 @default.
• W4213234788 cites W2179563633 @default.
• W4213234788 cites W2888290077 @default.
• W4213234788 cites W2889688444 @default.
• W4213234788 cites W2971720436 @default.
• W4213234788 cites W3024016733 @default.
• W4213234788 cites W3087229194 @default.
• W4213234788 cites W3093362765 @default.
• W4213234788 cites W3130459987 @default.
• W4213234788 doi "https://doi.org/10.1016/j.jcin.2021.11.040" @default.
• W4213234788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35210047" @default.
• W4213234788 hasPublicationYear "2022" @default.
• W4213234788 type Work @default.
• W4213234788 citedByCount "7" @default.
• W4213234788 countsByYear W42132347882020 @default.
• W4213234788 countsByYear W42132347882022 @default.
• W4213234788 countsByYear W42132347882023 @default.
• W4213234788 crossrefType "journal-article" @default.
• W4213234788 hasAuthorship W4213234788A5001295240 @default.
• W4213234788 hasAuthorship W4213234788A5003293616 @default.
• W4213234788 hasAuthorship W4213234788A5004321997 @default.
• W4213234788 hasAuthorship W4213234788A5006233522 @default.
• W4213234788 hasAuthorship W4213234788A5011918560 @default.
• W4213234788 hasAuthorship W4213234788A5013041243 @default.
• W4213234788 hasAuthorship W4213234788A5015795674 @default.
• W4213234788 hasAuthorship W4213234788A5016167046 @default.
• W4213234788 hasAuthorship W4213234788A5022050683 @default.
• W4213234788 hasAuthorship W4213234788A5023950438 @default.
• W4213234788 hasAuthorship W4213234788A5024321268 @default.
• W4213234788 hasAuthorship W4213234788A5026594391 @default.
• W4213234788 hasAuthorship W4213234788A5029966654 @default.
• W4213234788 hasAuthorship W4213234788A5030343009 @default.
• W4213234788 hasAuthorship W4213234788A5036972757 @default.
• W4213234788 hasAuthorship W4213234788A5037313822 @default.
• W4213234788 hasAuthorship W4213234788A5038392664 @default.
• W4213234788 hasAuthorship W4213234788A5039789130 @default.
• W4213234788 hasAuthorship W4213234788A5042455711 @default.
• W4213234788 hasAuthorship W4213234788A5042895855 @default.
• W4213234788 hasAuthorship W4213234788A5045386444 @default.
• W4213234788 hasAuthorship W4213234788A5045707517 @default.
• W4213234788 hasAuthorship W4213234788A5046485954 @default.
• W4213234788 hasAuthorship W4213234788A5049607555 @default.
• W4213234788 hasAuthorship W4213234788A5050556018 @default.
• W4213234788 hasAuthorship W4213234788A5050815815 @default.
• W4213234788 hasAuthorship W4213234788A5054565426 @default.

• next